recall
saveGraviti Pharmaceuticals Private Limited recall (Cls II)
October 29, 2025updated 5mo ago
community read0 votes
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03. — Reason: Failed Tablet/Capsule Specifications — Status: Ongoing
view source ↗Data sources
last refreshed 11m ago
Found something off?
same company · ±60 days · 2
🐶 often sniffed alongside
top 8- tagRecall4 co-mentions · 2 sources
- companyGraviti Pharmaceuticals Pvt Ltd2 co-mentions · 1 sources
- drugAUVELITY2 co-mentions · 1 sources
- drugFUROSEMIDE2 co-mentions · 1 sources
- drugbupropion2 co-mentions · 1 sources
- drugBUPROPION HYDROCHLORIDE2 co-mentions · 1 sources
- drugbupropion hydrochloride ER2 co-mentions · 1 sources
- drugbupropion hydrochloride MR2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that